AI and the Pharmaceutical Industry — Weekly 2026-W36
This page is a mechanical aggregation of the daily data and carries no commentary. See the daily pages for interpretation.
💰 Investment MapAmounts are extracted from source text by pattern matching only. No currency conversion.
| Amount | Deal | Function | Source |
|---|---|---|---|
| $2.22 Billion | Study on Artificial Intelligence (AI) Enabled Pharma Supply Chain Market Highlights Industry Expansion to $2.22 Billion | 🚚 Distribution / Supply Chain | openPR.com |
| $2 Billion | Dassault Systèmes to Acquire ArisGlobal for Up to $2 Billion, Integrating Life Sciences AI | 🏛️ Enterprise AI Platform & Governance | finance.biggo.com |
| $42 million | Smart toilet, AI platform among tech in use at drugmaker Eli Lilly’s new S$42 million hub in Singapore | 🏛️ Enterprise AI Platform & Governance | Singapore Economic Development Board (EDB) |
| €2.5M | Pharosyn Raises €2.5M for Pharma AI Intelligence Platform. | 🏛️ Enterprise AI Platform & Governance | konsulteer.com |
| $207,000 | Tempus AI Director Nadja West Sells 3,000 Shares for $207,000 | 🏛️ Enterprise AI Platform & Governance | The Motley Fool |
| — | Tempus AI pulling, refiling US antitrust paperwork for Personalis buyout | 🏛️ Enterprise AI Platform & Governance | MLex |
🧬 Drug Discovery6
- S2 Deal / PartnershipBenchSci Announces Two-Year Enterprise Agreement with argenx to Advance AI-Driven Preclinical Drug Discovery — Business Wire09/02 21:00 JST
- S2 Deal / PartnershipOno Pharmaceutical partners with US AI drug discovery company / Hodogaya Chemical establishes nucleic acid drug CDMO subsidiary — Pharmaceutical Industry Daily News Roundup (September 2, 2026) — Answers（アンサーズ）09/02 18:04 JST
- S2 Deal / PartnershipOno Pharmaceutical launches drug discovery partnership with US-based Aitia in the neurology field — leveraging digital twins built with cutting-edge causal AI — — 日経バイオテクONLINE09/02 21:29 JSTAitia
- S2 Deal / PartnershipIIT Kanpur partners with Nobel Laureate David Baker’s Lab for AI-guided drug discovery — biospectrumindia.com09/03 22:44 JST
- S2 Deal / PartnershipNotice of Conclusion of Joint Research Agreement with FRONTEO, Inc. on AI Drug Discovery — 日本経済新聞09/03 16:35 JST
- S2 Deal / PartnershipChaim---Surges, signs joint research agreement with FRONTEO on AI drug discovery — fr.tradingview.com09/04 02:59 JST
🧪 Clinical Development0
No items today · See past 90 days →
📑 CTD / Regulatory Submission0
No items today · See past 90 days →
🩺 GCP Operations0
No items today · See past 90 days →
📘 ICH Guidelines & AI0
No items today · See past 90 days →
🛡️ Pharmacovigilance / GVP0
No items today · See past 90 days →
📊 RWE / Evidence Generation0
No items today · See past 90 days →
🎓 Medical Affairs0
No items today · See past 90 days →
💼 Sales0
No items today · See past 90 days →
📣 Marketing0
No items today · See past 90 days →
🚚 Distribution / Supply Chain1
- S4 Amount disclosedStudy on Artificial Intelligence (AI) Enabled Pharma Supply Chain Market Highlights Industry Expansion to $2.22 Billion$2.22 Billion — openPR.com09/02 21:09 JST
✅ GQP / Quality Assurance0
No items today · See past 90 days →
👥 Human Resources1
- S1 DeploymentSaishunkan Pharmaceutical adopts AI calls, offering 24-hour support including early morning and nighttime — 通販新聞社09/04 17:14 JST
💴 Finance & Accounting0
No items today · See past 90 days →
🏛️ Enterprise AI Platform & Governance13
- S2 Deal / PartnershipMegazone and Hanmi Science partner to jointly develop pharmaceutical AI - CHOSUNBIZ — Chosunbiz08/31 16:00 JST
- S4 Amount disclosedDassault Systèmes to Acquire ArisGlobal for Up to $2 Billion, Integrating Life Sciences AI$2 Billion — finance.biggo.com09/01 12:26 JST
- S3 Capital moveTempus AI pulling, refiling US antitrust paperwork for Personalis buyout — MLex09/01 06:36 JSTTempus AI
- S2 Deal / PartnershipWeave Bio Announces Collaboration with Takeda to Deploy AI-Native Regulatory Automation Across Key Drug Development Activities — Business Wire09/01 22:00 JSTTakedaAlso reported by 1: marketscreener.com
- S1 DeploymentSaishunkan Pharmaceutical fully adopts AI voice operator — 週刊粧業オンライン09/01 11:30 JST
- S4 Amount disclosedSmart toilet, AI platform among tech in use at drugmaker Eli Lilly’s new S$42 million hub in Singapore$42 million — Singapore Economic Development Board (EDB)09/02 16:00 JSTEli Lilly
- S4 Amount disclosedTempus AI Director Nadja West Sells 3,000 Shares for $207,000$207,000 — The Motley Fool09/02 22:35 JSTTempus AI
- S2 Deal / PartnershipBoehringer Signs Deal for Owkin AI, Joining Astra and Sanofi — Bloomberg.com09/02 21:48 JSTSanofiOwkin
- S2 Deal / PartnershipOno Pharmaceutical partners with Aitia to hunt new brain-disease drug targets using causal AI — Dealroom09/02 16:12 JSTOno PharmaceuticalAitia
- S2 Deal / PartnershipCurveJen and Azabu University School of Veterinary Medicine take on AMR with One Health — jointly developing an AI system that identifies bovine mastitis-causing bacteria without relying on experience — 日経バイオテクONLINE09/02 21:29 JST
- S4 Amount disclosedPharosyn Raises €2.5M for Pharma AI Intelligence Platform.€2.5M — konsulteer.com09/03 15:33 JST
- S2 Deal / PartnershipBoehringer Ingelheim signs AI agreement with Owkin — medwatch.com09/04 17:02 JSTBoehringer IngelheimOwkin
- S1 DeploymentDoes Tempus AI’s (TEM) New ECG-PH Clearance Reveal Its Real Edge In Clinical AI Adoption? — simplywall.st09/05 05:20 JSTTempus AI